Liberty Mutual Group Asset Management Inc. Arcellx, Inc. Transaction History

Liberty Mutual Group Asset Management Inc.

$660 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 09, 2023	BUY	$17.18 - $33.0 $430,754 - $827,409	25,073 New	25,073 $777,000

Others Institutions Holding ACLX

# of Institutions

204

Shares Held

44.2M

Call Options Held

2.23M

Put Options Held

907K

Paradigm Biocapital Advisors LP New York, NY

4M
Shares

$313 Million
12.04% of portfolio
Perceptive Advisors LLC New York, NY

3.89M
Shares

$304 Million
8.48% of portfolio
Nea Management Company, LLC Timonium, MD

3.75M
Shares

$293 Million
23.89% of portfolio
Black Rock Inc. New York, NY

3.52M
Shares

$275 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.46M
Shares

$193 Million
0.0% of portfolio

View Full List

About Arcellx, Inc.

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.43B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

More about ACLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Account